Pharmacodynamic (PD) responses drive dose/schedule selection of CC-92480, a novel CELMoD agent, in a phase 1 dose-escalation study in relapsed/refractory multiple myeloma (RRMM).

被引：0

作者：

Wong, Lilly

Jimenez Nunez, Maria Dolores

Bahlis, Nizar J.

Vangsted, Annette J.

Ramasamy, Karthik

Trudel, Suzanne

Martinez, Joaquin

Mateos, Maria-Victoria

Rodriguez Otero, Paula

Lonial, Sagar

Popat, Rakesh

Oriol, Albert

Karanes, Chatchada

Orlowski, Robert Z.

Berdeja, Jesus G.

Wang, Maria

Lamba, Manisha

Pourdehnad, Michael

Pierce, Daniel W.

Richardson, Paul G.

机构：

[1] Bristol Myers Squibb, San Diego, CA USA

[2] Celgene Res SLU, Seville, CA, Spain

[3] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[4] Rigshosp, Dept Haematol, Copenhagen, Denmark

[5] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England

[6] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[7] Univ Complutense Madrid, Hosp Octubre 12, Dept Hematol, H120 CNIO Clin Res Unit,CIBERONC, Madrid, Spain

[8] Univ Hosp Salamanca IBSAL, Salamanca, Spain

[9] Univ Clin Navarra, Ctr Appl Med Res CIMA, IDISNA, Pamplona, Spain

[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[11] Univ Coll London Hosp NHS Fdn Trust, NIHR UCLH Clin Res Facil, London, England

[12] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain

[13] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Badalona, Spain

[14] City Hope Natl Med Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Duarte, CA USA

[15] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[16] Sarah Cannon Ctr Blood Canc, Nashville, TN USA

[17] Bristol Myers Squibb, Summit, NJ USA

[18] Bristol Myers Squibb, San Francisco, CA USA

[19] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8531

引用

页数：2

共 50 条

[41] Pharmacodynamic Responses to CC90009, a Novel Cereblon E3 Ligase Modulator, in a Phase I Dose-Escalation Study in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
Fan, Jinhong
Wang, Hongbin
Couto, Suzana
Sheena, Tsun-Wen
Uy, Geoffrey L.
Zeidan, Amer M.
Minden, Mark D.
Montesinos, Pau
DeAngelo, Daniel J.
Altman, Jessica K.
Koprivnikar, Jamie
Vyas, Paresh
Floisand, Yngvar
Belen Vidriales, Maria
Gjertsen, Bjorn Tore
Buchholz, Tonia J.
Pourdehnad, Michael
Pierce, Daniel W.
BLOOD, 2019, 134
[42] A phase 1, multi-center, dose escalation study of atiprimod in patients with refractory or relapsed multiple myeloma (MM).
Wang, M
Talpaz, M
Jagannath, S
Chanan-Khan, AA
Alexanian, R
Weber, DM
Gavino, M
Estrov, Z
Harris, PJ
Picker, D
Schlossman, RL
Tassone, P
Anderson, KC
Munshi, NC
BLOOD, 2005, 106 (11) : 36A - 37A
[43] SUBCUTANEOUS DARATUMUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION PHASE 1B STUDY (PAVO)
Mateos, M., V
Chari, A.
Nah, H.
Lokhorst, H.
Kaufman, J. L.
Moreau, P.
Oriol, A.
Plesner, T.
Benboubker, L.
Hellemans, P.
Masterson, T.
Clemens, P. L.
Liu, K.
San-Miguel, J.
Usmani, S. Z.
HAEMATOLOGICA, 2018, 103 : 32 - 33
[44] MOR202 with low-dose dexamethasone (Dex) and in combination with pomalidomide/dex and lenalidomide/dex in relapsed or refractory multiple myeloma (RRMM): Interim analysis of a phase I/IIa dose-escalation study.
Raab, Marc
Chatterjee, Manik
Goldschmidt, Hartmut
Agis, Hermine
Blau, Igor W.
Einsele, Hermann
Engelhardt, Monika Martha
Ferstl, Barbara
Gramatzki, Martin
Rollig, Christoph
Weisel, Katja C.
Jarutat, Tiantom
Weinelt, Dominika
Winderlich, Mark
Boxhammer, Rainer
Peschel, Christian
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[45] Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study (vol 150, pg 438, 2010)
Richardson, P. G.
Chanan-Khan, A. A.
Alsina, M.
Albitar, M.
Berman, M.
Messina, M.
Mitsiades, C. S.
Anderson, K. C.
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (06) : 731 - 731
[46] CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose-Escalation and Dose-Expansion Trial
Zhou, Huixing
Huang, Zhongxia
Fang, Baijun
Jing, Hongmei
Xia, Zhongjun
Song, Yuqin
Cai, Zhen
An, Gang
Qin, Ling
Bao, Li
Li, Xin
Liu, Yuzhang
Wang, Yanrong
Li, Ling
Chen, Wenming
AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 531 - 534
[47] PX-171-006, A PHASE IB DOSE-ESCALATION STUDY OF CARFILZOMIB plus LENALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Wang, M.
Bensinger, W.
Orlowski, R.
Alsina, M.
Martin, T.
Singhal, S.
Gabrail, N.
Vallone, M.
Kauffman, M.
Niesvizky, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 157 - 157
[48] Dose Escalation of ISB 1342, a Novel CD38xCD3 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma ( RRMM)
Kapoor, Prashant
Stevens, Don A.
Leleu, Xavier
Merzoug, Karim Belhadj
Karlin, Lionel
Manier, Salomon
Chalopin, Thomas
Hulin, Cyrille
Perrot, Aurore
Berdeja, Jesus G.
Chase, Cristiana Costa
Touzeau, Cyrille
Moreau, Philippe
Mohan, Sanjay
Lesokhin, Alexander
Huff, Carol
Vesole, David H.
Richter, Joshua
Matous, Jeffrey
Wolff, Eileen
Shah, Tejas
Koch-Olsen, Jeppe
Garton, Andrew
Menon, Vinu
Gn, Sunitha
Perro, Mario
Zhukovsky, Eugene
Konto, Cyril
Pacaud, Lida
Mohty, Mohamad
BLOOD, 2023, 142
[49] Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Pavo, an Open-Label, Multicenter, Dose Escalation Phase 1b Study
Chari, Ajai
Nahi, Hareth
Mateos, Maria-Victoria
Lokhorst, Henk M.
Kaufman, Jonathan L.
Moreau, Philippe
Oriol, Albert
Plesner, Torben
Benboubker, Lotfi
Hellemans, Peter
Masterson, Tara
Clemens, Pamela L.
Liu, Kevin
San-Miguel, Jesus F.
Usmani, Saad Z.
BLOOD, 2017, 130
[50] MM-004: A Phase 1, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, Efficacy, and Pharmacokinetics of Pomalidomide Alone or in Combination with Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma in Japan
Iida, Shinsuke
Iwasaki, Hiromi
Chou, Takaaki
Tobonai, Kensei
Sunami, Kazutaka
Ogawa, Yoshiaki
Kurihara, Mari
Midorikawa, Shuichi
Zaki, Mohamed H.
Doerr, Thomas
Matsue, Kosei
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →